APO Research
Talk to an analyst

APO RESEARCH · REPORT

Orlistat

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Orlistat Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025190 pages

Choose your research edition.

Industry ResearchOrlistat Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Orlistat Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Orlistat Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orlistat Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Orlistat Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Orlistat market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Orlistat is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Orlistat is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Orlistat is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Orlistat is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Orlistat include Teva, Sandoz(Novartis), Roche, GSK group, ZEIN pharmaceutical, Taj Pharmaceuticals Ltd, STADA-VN J.V.Co., Ltd, National Company for Pharmaceutical Industry and Lunan Pharmaceutical Group Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Orlistat market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Orlistat and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Orlistat sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Orlistat market size, projected growth trends, production technologies, key applications, and end-use industries.

Orlistat Segment by Company

Teva

Sandoz(Novartis)

Roche

GSK group

ZEIN pharmaceutical

Taj Pharmaceuticals Ltd

STADA-VN J.V.Co., Ltd

National Company for Pharmaceutical Industry

Lunan Pharmaceutical Group Corporation

Kabir Life Sciences & Research

HISUN

Hexal AG

DM Pharma

China Zhongshan Pharm

Orlistat Segment by Type

120mg Orlistat

60mg Orlistat

Orlistat Segment by Application

Weight-reducing Aid

Other

Orlistat Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orlistat market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orlistat and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orlistat.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Orlistat market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Orlistat manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Orlistat in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Orlistat in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Orlistat Industry Trends Table 2. Orlistat Industry Drivers Table 3. Orlistat Industry Opportunities and Challenges Table 4. Orlistat Industry Restraints Table 5. Global Orlistat Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Orlistat Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Orlistat Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Orlistat Sales Market Share by Manufacturers Table 9. Global Orlistat Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Orlistat Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Orlistat Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Orlistat Manufacturers, Product Type & Application Table 13. Global Orlistat Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Orlistat by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 120mg Orlistat Table 17. Major Manufacturers of 60mg Orlistat Table 18. Global Orlistat Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Orlistat Sales by Type (2021-2026) & (K Units) Table 20. Global Orlistat Sales by Type (2027-2032) & (K Units) Table 21. Global Orlistat Sales Market Share by Type (2021-2026) Table 22. Global Orlistat Sales Market Share by Type (2027-2032) Table 23. Global Orlistat Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Orlistat Revenue by Type (2021-2026) & (K Units) Table 25. Global Orlistat Revenue by Type (2027-2032) & (K Units) Table 26. Global Orlistat Revenue Market Share by Type (2021-2026) Table 27. Global Orlistat Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Weight-reducing Aid Table 29. Major Manufacturers of Other Table 30. Global Orlistat Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Orlistat Sales by Application (2021-2026) & (K Units) Table 32. Global Orlistat Sales by Application (2027-2032) & (K Units) Table 33. Global Orlistat Sales Market Share by Application (2021-2026) Table 34. Global Orlistat Sales Market Share by Application (2027-2032) Table 35. Global Orlistat Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Orlistat Revenue by Application (2021-2026) & (K Units) Table 37. Global Orlistat Revenue by Application (2027-2032) & (K Units) Table 38. Global Orlistat Revenue Market Share by Application (2021-2026) Table 39. Global Orlistat Revenue Market Share by Application (2027-2032) Table 40. Global Orlistat Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Orlistat Sales by Region (2021-2026) & (K Units) Table 42. Global Orlistat Sales Market Share by Region (2021-2026) Table 43. Global Orlistat Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Orlistat Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Orlistat Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Orlistat Sales by Country (2021-2026) & (K Units) Table 47. North America Orlistat Sales by Country (2027-2032) & (K Units) Table 48. Europe Orlistat Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Orlistat Sales by Country (2021-2026) & (K Units) Table 50. Europe Orlistat Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Orlistat Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Orlistat Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Orlistat Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Orlistat Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Orlistat Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Orlistat Sales by Country (2027-2032) & (K Units) Table 57. Global Orlistat Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Orlistat Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Orlistat Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Orlistat Revenue Market Share by Region (2021-2026) Table 61. Global Orlistat Revenue Market Share by Region (2027-2032) Table 62. Teva Company Information Table 63. Teva Business Overview Table 64. Teva Orlistat Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Teva Orlistat Product Portfolio Table 66. Teva Recent Development Table 67. Sandoz(Novartis) Company Information Table 68. Sandoz(Novartis) Business Overview Table 69. Sandoz(Novartis) Orlistat Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Sandoz(Novartis) Orlistat Product Portfolio Table 71. Sandoz(Novartis) Recent Development Table 72. Roche Company Information Table 73. Roche Business Overview Table 74. Roche Orlistat Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Roche Orlistat Product Portfolio Table 76. Roche Recent Development Table 77. GSK group Company Information Table 78. GSK group Business Overview Table 79. GSK group Orlistat Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. GSK group Orlistat Product Portfolio Table 81. GSK group Recent Development Table 82. ZEIN pharmaceutical Company Information Table 83. ZEIN pharmaceutical Business Overview Table 84. ZEIN pharmaceutical Orlistat Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. ZEIN pharmaceutical Orlistat Product Portfolio Table 86. ZEIN pharmaceutical Recent Development Table 87. Taj Pharmaceuticals Ltd Company Information Table 88. Taj Pharmaceuticals Ltd Business Overview Table 89. Taj Pharmaceuticals Ltd Orlistat Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Taj Pharmaceuticals Ltd Orlistat Product Portfolio Table 91. Taj Pharmaceuticals Ltd Recent Development Table 92. STADA-VN J.V.Co., Ltd Company Information Table 93. STADA-VN J.V.Co., Ltd Business Overview Table 94. STADA-VN J.V.Co., Ltd Orlistat Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. STADA-VN J.V.Co., Ltd Orlistat Product Portfolio Table 96. STADA-VN J.V.Co., Ltd Recent Development Table 97. National Company for Pharmaceutical Industry Company Information Table 98. National Company for Pharmaceutical Industry Business Overview Table 99. National Company for Pharmaceutical Industry Orlistat Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. National Company for Pharmaceutical Industry Orlistat Product Portfolio Table 101. National Company for Pharmaceutical Industry Recent Development Table 102. Lunan Pharmaceutical Group Corporation Company Information Table 103. Lunan Pharmaceutical Group Corporation Business Overview Table 104. Lunan Pharmaceutical Group Corporation Orlistat Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Lunan Pharmaceutical Group Corporation Orlistat Product Portfolio Table 106. Lunan Pharmaceutical Group Corporation Recent Development Table 107. Kabir Life Sciences & Research Company Information Table 108. Kabir Life Sciences & Research Business Overview Table 109. Kabir Life Sciences & Research Orlistat Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Kabir Life Sciences & Research Orlistat Product Portfolio Table 111. Kabir Life Sciences & Research Recent Development Table 112. HISUN Company Information Table 113. HISUN Business Overview Table 114. HISUN Orlistat Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. HISUN Orlistat Product Portfolio Table 116. HISUN Recent Development Table 117. Hexal AG Company Information Table 118. Hexal AG Business Overview Table 119. Hexal AG Orlistat Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Hexal AG Orlistat Product Portfolio Table 121. Hexal AG Recent Development Table 122. DM Pharma Company Information Table 123. DM Pharma Business Overview Table 124. DM Pharma Orlistat Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. DM Pharma Orlistat Product Portfolio Table 126. DM Pharma Recent Development Table 127. China Zhongshan Pharm Company Information Table 128. China Zhongshan Pharm Business Overview Table 129. China Zhongshan Pharm Orlistat Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. China Zhongshan Pharm Orlistat Product Portfolio Table 131. China Zhongshan Pharm Recent Development Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Orlistat Distributors List Table 135. Orlistat Customers List Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Orlistat Product Image Figure 2. Global Orlistat Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Orlistat Market Size (2021-2032) & (US$ Million) Figure 4. Global Orlistat Sales (2021-2032) & (K Units) Figure 5. Global Orlistat Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Orlistat Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 120mg Orlistat Image Figure 9. 60mg Orlistat Image Figure 10. Global Orlistat Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Orlistat Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Orlistat Sales Market Share by Type (2021-2032) Figure 13. Global Orlistat Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Orlistat Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Orlistat Revenue Market Share by Type (2021-2032) Figure 16. Weight-reducing Aid Image Figure 17. Other Image Figure 18. Global Orlistat Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Orlistat Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Orlistat Sales Market Share by Application (2021-2032) Figure 21. Global Orlistat Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Orlistat Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Orlistat Revenue Market Share by Application (2021-2032) Figure 24. North America Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Orlistat Sales Market Share by Country (2021-2032) Figure 26. U.S. Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Orlistat Sales Market Share by Country (2021-2032) Figure 31. Germany Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Orlistat Sales Market Share by Country (2021-2032) Figure 38. China Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Orlistat Sales Market Share by Country (2021-2032) Figure 46. Brazil Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Orlistat Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Orlistat Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Orlistat Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Orlistat Revenue (2021-2032) & (US$ Million) Figure 57. North America Orlistat Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Orlistat Revenue (2021-2032) & (US$ Million) Figure 59. Europe Orlistat Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Orlistat Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Orlistat Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Orlistat Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Orlistat Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Orlistat Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Orlistat Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 120mg Orlistat
  • 60mg Orlistat
Applications
  • Weight-reducing Aid
  • Other
Companies covered
  • Teva
  • Sandoz(Novartis)
  • Roche
  • GSK group
  • ZEIN pharmaceutical
  • Taj Pharmaceuticals Ltd
  • STADA-VN J.V.Co., Ltd
  • National Company for Pharmaceutical Industry
  • Lunan Pharmaceutical Group Corporation
  • Kabir Life Sciences & Research
  • HISUN
  • Hexal AG
  • DM Pharma
  • China Zhongshan Pharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Orlistat Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Orlistat Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Orlistat Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Orlistat Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Orlistat Market Dynamics
  1. 2.1 Orlistat Industry Trends
  2. 2.2 Orlistat Industry Drivers
  3. 2.3 Orlistat Industry Opportunities and Challenges
  4. 2.4 Orlistat Industry Restraints
3 Orlistat Market by Manufacturers
  1. 3.1 Global Orlistat Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Orlistat Sales by Manufacturers (2021-2026)
  3. 3.3 Global Orlistat Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Orlistat Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Orlistat Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Orlistat Manufacturers, Product Type & Application
  7. 3.7 Global Orlistat Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Orlistat Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Orlistat Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Orlistat Tier 1, Tier 2, and Tier 3
4 Orlistat Market by Type
  1. 4.1 Orlistat Type Introduction
  2. 4.1.1 120mg Orlistat
  3. 4.1.2 60mg Orlistat
  4. 4.2 Global Orlistat Sales by Type
  5. 4.2.1 Global Orlistat Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Orlistat Sales by Type (2021-2032)
  7. 4.2.3 Global Orlistat Sales Market Share by Type (2021-2032)
  8. 4.3 Global Orlistat Revenue by Type
  9. 4.3.1 Global Orlistat Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Orlistat Revenue by Type (2021-2032)
  11. 4.3.3 Global Orlistat Revenue Market Share by Type (2021-2032)
5 Orlistat Market by Application
  1. 5.1 Orlistat Application Introduction
  2. 5.1.1 Weight-reducing Aid
  3. 5.1.2 Other
  4. 5.2 Global Orlistat Sales by Application
  5. 5.2.1 Global Orlistat Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Orlistat Sales by Application (2021-2032)
  7. 5.2.3 Global Orlistat Sales Market Share by Application (2021-2032)
  8. 5.3 Global Orlistat Revenue by Application
  9. 5.3.1 Global Orlistat Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Orlistat Revenue by Application (2021-2032)
  11. 5.3.3 Global Orlistat Revenue Market Share by Application (2021-2032)
6 Global Orlistat Sales by Region
  1. 6.1 Global Orlistat Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Orlistat Sales by Region (2021-2032)
  3. 6.2.1 Global Orlistat Sales by Region (2021-2026)
  4. 6.2.2 Global Orlistat Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Orlistat Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Orlistat Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Orlistat Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Orlistat Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Orlistat Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Orlistat Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Orlistat Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Orlistat Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Orlistat Revenue by Region
  1. 7.1 Global Orlistat Revenue by Region
  2. 7.1.1 Global Orlistat Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Orlistat Revenue by Region (2021-2026)
  4. 7.1.3 Global Orlistat Revenue by Region (2027-2032)
  5. 7.1.4 Global Orlistat Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Orlistat Revenue (2021-2032)
  8. 7.2.2 North America Orlistat Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Orlistat Revenue (2021-2032)
  11. 7.3.2 Europe Orlistat Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Orlistat Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Orlistat Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Orlistat Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Orlistat Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Orlistat Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Orlistat Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sandoz(Novartis)
  8. 8.2.1 Sandoz(Novartis) Company Information
  9. 8.2.2 Sandoz(Novartis) Business Overview
  10. 8.2.3 Sandoz(Novartis) Orlistat Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz(Novartis) Orlistat Product Portfolio
  12. 8.2.5 Sandoz(Novartis) Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche Orlistat Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche Orlistat Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 GSK group
  20. 8.4.1 GSK group Company Information
  21. 8.4.2 GSK group Business Overview
  22. 8.4.3 GSK group Orlistat Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GSK group Orlistat Product Portfolio
  24. 8.4.5 GSK group Recent Developments
  25. 8.5 ZEIN pharmaceutical
  26. 8.5.1 ZEIN pharmaceutical Company Information
  27. 8.5.2 ZEIN pharmaceutical Business Overview
  28. 8.5.3 ZEIN pharmaceutical Orlistat Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ZEIN pharmaceutical Orlistat Product Portfolio
  30. 8.5.5 ZEIN pharmaceutical Recent Developments
  31. 8.6 Taj Pharmaceuticals Ltd
  32. 8.6.1 Taj Pharmaceuticals Ltd Company Information
  33. 8.6.2 Taj Pharmaceuticals Ltd Business Overview
  34. 8.6.3 Taj Pharmaceuticals Ltd Orlistat Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Taj Pharmaceuticals Ltd Orlistat Product Portfolio
  36. 8.6.5 Taj Pharmaceuticals Ltd Recent Developments
  37. 8.7 STADA-VN J.V.Co., Ltd
  38. 8.7.1 STADA-VN J.V.Co., Ltd Company Information
  39. 8.7.2 STADA-VN J.V.Co., Ltd Business Overview
  40. 8.7.3 STADA-VN J.V.Co., Ltd Orlistat Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 STADA-VN J.V.Co., Ltd Orlistat Product Portfolio
  42. 8.7.5 STADA-VN J.V.Co., Ltd Recent Developments
  43. 8.8 National Company for Pharmaceutical Industry
  44. 8.8.1 National Company for Pharmaceutical Industry Company Information
  45. 8.8.2 National Company for Pharmaceutical Industry Business Overview
  46. 8.8.3 National Company for Pharmaceutical Industry Orlistat Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 National Company for Pharmaceutical Industry Orlistat Product Portfolio
  48. 8.8.5 National Company for Pharmaceutical Industry Recent Developments
  49. 8.9 Lunan Pharmaceutical Group Corporation
  50. 8.9.1 Lunan Pharmaceutical Group Corporation Company Information
  51. 8.9.2 Lunan Pharmaceutical Group Corporation Business Overview
  52. 8.9.3 Lunan Pharmaceutical Group Corporation Orlistat Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lunan Pharmaceutical Group Corporation Orlistat Product Portfolio
  54. 8.9.5 Lunan Pharmaceutical Group Corporation Recent Developments
  55. 8.10 Kabir Life Sciences & Research
  56. 8.10.1 Kabir Life Sciences & Research Company Information
  57. 8.10.2 Kabir Life Sciences & Research Business Overview
  58. 8.10.3 Kabir Life Sciences & Research Orlistat Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Kabir Life Sciences & Research Orlistat Product Portfolio
  60. 8.10.5 Kabir Life Sciences & Research Recent Developments
  61. 8.11 HISUN
  62. 8.11.1 HISUN Company Information
  63. 8.11.2 HISUN Business Overview
  64. 8.11.3 HISUN Orlistat Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 HISUN Orlistat Product Portfolio
  66. 8.11.5 HISUN Recent Developments
  67. 8.12 Hexal AG
  68. 8.12.1 Hexal AG Company Information
  69. 8.12.2 Hexal AG Business Overview
  70. 8.12.3 Hexal AG Orlistat Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hexal AG Orlistat Product Portfolio
  72. 8.12.5 Hexal AG Recent Developments
  73. 8.13 DM Pharma
  74. 8.13.1 DM Pharma Company Information
  75. 8.13.2 DM Pharma Business Overview
  76. 8.13.3 DM Pharma Orlistat Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 DM Pharma Orlistat Product Portfolio
  78. 8.13.5 DM Pharma Recent Developments
  79. 8.14 China Zhongshan Pharm
  80. 8.14.1 China Zhongshan Pharm Company Information
  81. 8.14.2 China Zhongshan Pharm Business Overview
  82. 8.14.3 China Zhongshan Pharm Orlistat Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 China Zhongshan Pharm Orlistat Product Portfolio
  84. 8.14.5 China Zhongshan Pharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Orlistat Value Chain Analysis
  2. 9.1.1 Orlistat Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Orlistat Production Mode & Process
  6. 9.2 Orlistat Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Orlistat Distributors
  9. 9.2.3 Orlistat Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst